6879 logo

TCI GENE Inc. Stock Price

TPEX:6879 Community·NT$979.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6879 Share Price Performance

NT$37.00
-6.90 (-15.72%)
NT$37.00
-6.90 (-15.72%)
Price NT$37.00

6879 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

TCI GENE Inc. Key Details

NT$273.6m

Revenue

NT$121.0m

Cost of Revenue

NT$152.6m

Gross Profit

NT$112.0m

Other Expenses

NT$40.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.53
55.77%
14.83%
0%
View Full Analysis

About 6879

Founded
2011
Employees
n/a
CEO
n/a
WebsiteView website
www.tci-gene.com

TCI GENE Inc., together with its subsidiaries, provides genetic testing and assessment services in Taiwan and Mainland China. It operates through Inspection and Consumable Products segments. The company offers memory, anti-aging, health management, child growth and development, nutritional metabolism and absorption, OB weight management, and SC skin management genetic testing; gut microbiota testing; and LDT cardiovascular drug gene testing services. It also provides precision prediction and personalized health management plans; and adipose-derived mesenchymal stem cells, natural killer immune cells, and immune cell storage programs. In addition, the company manufactures and sells testing reagents, health food, and beauty products; and health and nutritional supplements. TCI GENE Inc. was founded in 2011 and is based in Taipei, Taiwan.

Recent 6879 News & Updates

Recent updates

No updates